Search research articles
Contact Us
Filters
Showing results (181-190 of 196) with videos related to
Page
of 20
Sort By:
BMJ Open
|
February 7, 2025
Trial protocol of an open-label pilot study of oral <u>na</u>ltrexone-<u>bu</u>propion combination pharmacotherapy for the treatment of methamphetamine use disorder (the NABU trial)
Krista J Siefried, Liam Acheson, Brendan Clifford, et al.
BMJ Open
|
August 3, 2024
Implementation of time-limited parenteral hydromorphone in people with treatment-resistant injecting opioid use disorder: a protocol for a single-site, uncontrolled, open-label study to assess feasibility, safety and cost
Craig Rodgers, Krista J Siefried, Alison Ritter, et al.
Addiction (Abingdon, England)
|
June 29, 2021
Treatment of opioid dependence with depot buprenorphine (CAM2038) in custodial settings
Adrian J Dunlop, Bethany White, Jillian Roberts, et al.
JAMA Internal Medicine
|
July 16, 2019
Nabiximols for the Treatment of Cannabis Dependence: A Randomized Clinical Trial
Nicholas Lintzeris, Anjali Bhardwaj, Llewellyn Mills, et al.
Drug and Alcohol Review
|
June 3, 2025
Hydromorphone Hopes: A Qualitative Study of People Initiating Supervised Short-Acting Injectable Opioid Treatment in Australia
Jake Rance, Vendula Belackova, James Bell, et al.
The International Journal on Drug Policy
|
November 4, 2021
Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependence
Michael Farrell, Jeyran Shahbazi, Marianne Byrne, et al.
The International Journal on Drug Policy
|
March 24, 2024
96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trial
Michael Farrell, Jeyran Shahbazi, Mark Chambers, et al.
Journal of Pain and Symptom Management
|
February 23, 2025
Design Considerations for Medicinal Cannabis Clinical Trials in People Receiving Palliative Care
Valentina Razmovski-Naumovski, Jennifer H Martin, Richard Chye, et al.
Addiction (Abingdon, England)
|
December 19, 2024
Lisdexamfetamine in the treatment of methamphetamine dependence: A randomised, placebo-controlled trial
Nadine Ezard, Brendan Clifford, Krista J Siefried, et al.
Drug and Alcohol Review
|
November 28, 2019
Designing, implementing and evaluating the overdose response with take-home naloxone model of care: An evaluation of client outcomes and perspectives
Nicholas Lintzeris, Lauren A Monds, Maria Bravo, et al.
Page
of 20
Search research articles
Search
Showing results (181-190 of 196) with videos related to
Sort By:
Page
of 20
BMJ Open
|
February 7, 2025
Trial protocol of an open-label pilot study of oral <u>na</u>ltrexone-<u>bu</u>propion combination pharmacotherapy for the treatment of methamphetamine use disorder (the NABU trial)
Krista J Siefried, Liam Acheson, Brendan Clifford, et al.
BMJ Open
|
August 3, 2024
Implementation of time-limited parenteral hydromorphone in people with treatment-resistant injecting opioid use disorder: a protocol for a single-site, uncontrolled, open-label study to assess feasibility, safety and cost
Craig Rodgers, Krista J Siefried, Alison Ritter, et al.
Addiction (Abingdon, England)
|
June 29, 2021
Treatment of opioid dependence with depot buprenorphine (CAM2038) in custodial settings
Adrian J Dunlop, Bethany White, Jillian Roberts, et al.
JAMA Internal Medicine
|
July 16, 2019
Nabiximols for the Treatment of Cannabis Dependence: A Randomized Clinical Trial
Nicholas Lintzeris, Anjali Bhardwaj, Llewellyn Mills, et al.
Drug and Alcohol Review
|
June 3, 2025
Hydromorphone Hopes: A Qualitative Study of People Initiating Supervised Short-Acting Injectable Opioid Treatment in Australia
Jake Rance, Vendula Belackova, James Bell, et al.
The International Journal on Drug Policy
|
November 4, 2021
Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependence
Michael Farrell, Jeyran Shahbazi, Marianne Byrne, et al.
The International Journal on Drug Policy
|
March 24, 2024
96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trial
Michael Farrell, Jeyran Shahbazi, Mark Chambers, et al.
Journal of Pain and Symptom Management
|
February 23, 2025
Design Considerations for Medicinal Cannabis Clinical Trials in People Receiving Palliative Care
Valentina Razmovski-Naumovski, Jennifer H Martin, Richard Chye, et al.
Addiction (Abingdon, England)
|
December 19, 2024
Lisdexamfetamine in the treatment of methamphetamine dependence: A randomised, placebo-controlled trial
Nadine Ezard, Brendan Clifford, Krista J Siefried, et al.
Drug and Alcohol Review
|
November 28, 2019
Designing, implementing and evaluating the overdose response with take-home naloxone model of care: An evaluation of client outcomes and perspectives
Nicholas Lintzeris, Lauren A Monds, Maria Bravo, et al.
Page
of 20